Aneuvo
Overview
ANEUVO is a therapy development company operating in the neurotech sector, headquartered in Los Angeles. The company focuses on treating disabling diseases and conditions that traditional pharmaceutical approaches have not been able to cure. ANEUVO has developed the ExaStim® Stimulation System, a non-invasive neuromodulation system that has received CE Mark approval and FDA Breakthrough Device Designation for the treatment of spinal cord injury. Currently, ExaStim® is only cleared for use in Europe and is not commercially available in other regions. In the United States, its use is limited to investigational purposes.
Details
- Category
- Medical Equipment Manufacturing
- Headquarters
- Los Angeles
- Type
- Privately Held
- Specialties
- neuromodulation, spinal cord injury, neuro rehabilitation, neurostimulation, medtech, paralysis, neurostim, physiotherapy, sci, and biotech
- Locations
- Los Angeles, us
Funding
Total rounds: 5
Last round: Series B, May 27, 2022